Blockade of AT1R and activation of AT2R reverse hypertension-induced cerebrovascular dysfunction and improve barrier function of endothelial cells and diabetes-associated cerebral endothelial dysfunction (122–124). This evidence concerns the gene AGTR1 and hypertensive disorder.